Conivaptan impurity
- Product Name
- Conivaptan impurity
- CAS No.
- 1129433-63-1
- Chemical Name
- Conivaptan impurity
- Synonyms
- Conivaptan-d4;N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl-d4]-[1,1'-biphenyl]-2-carboxamide
- CBNumber
- CB03144862
- Molecular Formula
- C32H26N4O2
- Formula Weight
- 498.59
- MOL File
- 1129433-63-1.mol
Conivaptan impurity Property
- storage temp.
- Store at -20°C
- solubility
- DMSO: soluble
- form
- A solid
N-Bromosuccinimide Price
- Product number
- 26455
- Product name
- Conivaptan-d4
- Packaging
- 500μg
- Price
- $194
- Updated
- 2024/03/01
- Product number
- 26455
- Product name
- Conivaptan-d4
- Packaging
- 1mg
- Price
- $369
- Updated
- 2024/03/01
- Product number
- 3226DC
- Product name
- 2-Phenyl-N-[2,3,5,6-tetradeuterio-4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]benzamide
- Packaging
- 1mg
- Price
- $753
- Updated
- 2021/12/16
Conivaptan impurity Chemical Properties,Usage,Production
Biological Activity
Conivaptan-d4 is intended for use as an internal standard for the quantification of conivaptan by GC- or LC-MS. Conivaptan is an antagonist of the arginine vasopressin (AVP) receptors V1A and V2 (Kis = 0.48 and 3.04 nM for rat liver V1A and kidney V2, respectively).1 It also competitively inhibits oxytocin binding to rat uterine oxytocin receptors (Ki = 44 nM) but has no effect on AVP binding to anterior pituitary V1B receptors at concentrations up to 100 μM in a radioligand binding assay. Conivaptan suppresses AVP-induced increases in intracellular calcium in vascular smooth muscle cells (VSMCs) in vitro and the pressor response in pithed rats. Conivaptan (0.01-0.3 mg/kg, i.v.) increases urine output and decreases urine osmolality in dehydrated conscious rats in a dose-dependent manner. It also reduces brain edema and blood-brain barrier disruption in a mouse experimental stroke model.2
References
1.Tahara, A., Tomura, Y., Wada, K.-I., et al.Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivoJ. Pharmacol. Exp. Ther.282(1)301-308(1997) 2.Zeynalov, E., Jones, S.M., Seo, J.W., et al.Arginine-vasopressin receptor blocker conivaptan reduces brain edema and blood-brain barrier disruption after experimental stroke in micePLoS One10(8)e0136121(2015)
Conivaptan impurity Preparation Products And Raw materials
Raw materials
Preparation Products
Conivaptan impurity Suppliers
- Tel
- +86-400-851-9921
- Fax
- +86-10-82826195
- sales@pharmacodia.com
- Country
- China
- ProdList
- 2317
- Advantage
- 55
- Tel
- 0755-0755-0755-83725350 13380397412
- Fax
- 0755-28094224
- 3001280422@qq.com
- Country
- China
- ProdList
- 9967
- Advantage
- 58
- Tel
- 021-021-51600108 13062666369
- sales@chinaisotope.com
- Country
- China
- ProdList
- 4271
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11974
- Advantage
- 58
- Tel
- 18627753421 18576690171
- Fax
- QQ:3001051413
- 3001009495@qq.com
- Country
- China
- ProdList
- 11124
- Advantage
- 58
- Tel
- 58896805
- 7993601name@qq.com
- Country
- CHINA
- ProdList
- 14775
- Advantage
- 58